RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTtnsK @bmj_c…
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTtnsK @bmj_c…
A tweetorial on vaccine response in COVID19 and IBD patients from Professor David Rubin which addresses many concerns relevant to our U.K. patients 👇
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
An eloquent explanation and clarification of a recent #covidvaccine study in #ibd patients. Thank you @IBDMD for sharing!
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
Whole thread!! So important and much appreciated info!!
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
@andrea4animals This one is UK based and is specific to folks with Inflammatory Bowel Disease, but is some of the only real information I’ve come across: https://t.co/vkEaNBRWIn
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTtnsK @bmj_company @Gut_BMJ
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
Important 🧵 by the @IBDMD ...
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
Good critique about a nytimes article on immunocompromised individuals being unable to take the vaccine. It's not so simple when it comes to those on IBD medications. Further lessons in the complexity of the immune system.
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
I read the NYT article and the Kennedy paper and was concerned about how they might be confusing. I was also confused until I had more context. Please read this entire thread and get your vaccine when you get the chance. #IBD
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in Gut). I've previously commented about the Kennedy paper in this forum, but it bears repeating and further explanation now. 1/ h
RT @kenichinalita: 大麻の方々はあんまり興味無いかもだけど、自己免疫疾患内輪話。 ぼちぼち身内でもワクチン接種の報が出て来たので念の為リサーチ。コレはインフリキシマブ(レミケード)だけど、抗TNF-αバイオ使っている人は(僕はアダリムマブ)参考になるかと思うの…
大麻の方々はあんまり興味無いかもだけど、自己免疫疾患内輪話。 ぼちぼち身内でもワクチン接種の報が出て来たので念の為リサーチ。コレはインフリキシマブ(レミケード)だけど、抗TNF-αバイオ使っている人は(僕はアダリムマブ)参考になるかと思うので頭の片隅に入れて判断を。 https://t.co/jKePOu4t6a
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @fgomollon: @Elena38845461 @JosReyesMoreno2 @geteccu @EiiInca @aegastro @jocamaga1974 @DeMadaria @drapereza Interesante opinión, no fund…
RT @fgomollon: @Elena38845461 @JosReyesMoreno2 @geteccu @EiiInca @aegastro @jocamaga1974 @DeMadaria @drapereza Interesante opinión, no fund…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
@Elena38845461 @JosReyesMoreno2 @geteccu @EiiInca @aegastro @jocamaga1974 @DeMadaria @drapereza Interesante opinión, no fundada en datos. Hasta el momento, en efectividad (evaluado en población real final) no se han encontrado diferencias; y en #EII no ga
RT @tariqahmadIBD: U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @docwifeandmum: @ExeterCathedral featuring on the front cover of @Gut_BMJ. A nice tribute to the @clarityibd and @RDEhospitals Exeter ga…
RT @tariqahmadIBD: U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients…
RT @clarityibd: Thank you 🙏 @Gut_BMJ - a lovely photo of Exeter Cathedral - did you know that it has the longest uninterrupted medieval sto…
RT @tariqahmadIBD: U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @tariqahmadIBD: U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients…
RT @tariqahmadIBD: U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients…
RT @tariqahmadIBD: U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients…
RT @clarityibd: Thank you 🙏 @Gut_BMJ - a lovely photo of Exeter Cathedral - did you know that it has the longest uninterrupted medieval sto…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
U.K. IBD collaborative research delivers important data. Thanks to @NIHRresearch @NIHRSW @CrohnsColitisUK 7000 patients and 92 U.K. hospitals. 👏👏👏 Please stick with the study, more data to follow.
RT @docwifeandmum: @ExeterCathedral featuring on the front cover of @Gut_BMJ. A nice tribute to the @clarityibd and @RDEhospitals Exeter ga…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @clarityibd: Thank you 🙏 @Gut_BMJ - a lovely photo of Exeter Cathedral - did you know that it has the longest uninterrupted medieval sto…
Thank you 🙏 @Gut_BMJ - a lovely photo of Exeter Cathedral - did you know that it has the longest uninterrupted medieval stone vaulted ceiling in the world. ❓Did you also know that #TeamClarity involved over 550 research staff + recruiting 7000 patient in
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
RT @Gut_BMJ: #GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @J…
#GUTFrontCover for May 2021 is Exeter Cathedral in SW England Read in this issue the paper by @DrNickKennedy @tariqahmadIBD @JamesGoodhand1 @NickPowellLab @ClaireBewshea @clarityibd on the effect of infliximab on anti-SARS-CoV2 antibody responses via https
Awaiting vaccinated data...
Seroprevalence, seroconversion and the magnitude of anti-SARS-CoV-2 antibody reactivity was significantly attenuated in infliximab-treated patients compared with vedolizumab-treated patients.
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/jXaxc5ZoL5
RT @SarahJTodd: 1st publication from the IBD Clarity trial now out in Gut. Marked attenuation in vaccine response (sAbs) in those on inflix…
RT @samplease: @stephenfloor Somewhat it appears, but not clear about T-cell based immunity I’m sure. https://t.co/Zk21IVa6JA
Concerning...https://t.co/cxTilyhjhi #IBD @bmj_latest. Thoughts?
@mctucsf looks like there's some very fresh data on this and it's not great: https://t.co/Qb5PUF8sfi
@stephenfloor Somewhat it appears, but not clear about T-cell based immunity I’m sure. https://t.co/Zk21IVa6JA
RT @sepdigestiva: Infliximab is associated with attenuated serological responses to SARS-CoV-2 that were further blunted by immunomodulator…
Infliximab is associated with attenuated serological responses to SARS-CoV-2 that were further blunted by immunomodulators used as concomitant therapy. ✍️@JamesGoodhand1, @ClaireBewshea, @nchanchlani1 et al. DOI: 10.1136/gutjnl-2021-324388 👉https://t.
RT @SarahJTodd: 1st publication from the IBD Clarity trial now out in Gut. Marked attenuation in vaccine response (sAbs) in those on inflix…
1st publication from the IBD Clarity trial now out in Gut. Marked attenuation in vaccine response (sAbs) in those on infliximab therapy. https://t.co/55QEWNvVKV
RT @charlie_lees: Have you seen the new data from @clarityibd released today as a pre-print? Check out the YouTube link below for 20 minu…
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
RT @MartaCalvo12: Resumen sobre la respuesta serológica al SARS-CoV2 y a las vacunas. Gracias 😍
RT @RomainM45081967: @gorka_orive Depende del público. UK y Canada lo hacen posponiendo seconda dosis a 3-4 meses. https://t.co/vQu0hOy7hn
2/2 new video updates (29/03/2021) from @charlie_lees on COVID and COVID &IBD @clarityibd results Remember Hands. Face. Space. Fresh air
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
@nataliexdean @NateSilver538 Thanks! What % of people are not having an immune response? While I'm sure this is a small subset, I spotted a recent study showing muted response - https://t.co/g0B9h768EG
RT @charlie_lees: Have you seen the new data from @clarityibd released today as a pre-print? Check out the YouTube link below for 20 minu…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
@gorka_orive Depende del público. UK y Canada lo hacen posponiendo seconda dosis a 3-4 meses. https://t.co/vQu0hOy7hn
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…
RT @charlie_lees: Anti-TNF & COVID-19 @clarityibd IFX vs VEDO in IBD (n=7226) Two important publications in a week. 1) serological resp…